These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20066534)

  • 1. Pneumocystis jiroveci pneumonia detected by FDG-PET.
    Nakazato T; Mihara A; Sanada Y; Suzuki K; Aisa Y; Iwabuchi M; Kakimoto T
    Ann Hematol; 2010 Aug; 89(8):839-40. PubMed ID: 20066534
    [No Abstract]   [Full Text] [Related]  

  • 2. FDG PET Imaging in Pneumocystis Pneumonia.
    Kono M; Yamashita H; Kubota K; Kano T; Mimori A
    Clin Nucl Med; 2015 Aug; 40(8):679-81. PubMed ID: 26018696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pneumocystis jiroveci pneumonia in an immunocompetent female patient].
    Nejmi H; Ziati J; Tijani A; Charaf K; Eladib AR; Younous S; Samkaoui MA; Zougari L
    Med Mal Infect; 2010 Apr; 40(4):241-2. PubMed ID: 19783112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis jirovecii in a bronchoalveolar lavage specimen on ThinPrep® cytology.
    Tyler KL; Selvaggi SM; Stewart J
    Diagn Cytopathol; 2011 Sep; 39(9):675-6. PubMed ID: 20949463
    [No Abstract]   [Full Text] [Related]  

  • 5. FDG-PET imaging in Pneumocystis carinii pneumonia.
    Win Z; Todd J; Al-Nahhas A
    Clin Nucl Med; 2005 Oct; 30(10):690-1. PubMed ID: 16166846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory diagnosis of Pneumocystis pneumonia--new developments].
    Riebold D; Fritzsche C; Lademann M; Reisinger EC
    Dtsch Med Wochenschr; 2005 Jun; 130(22):1377-80. PubMed ID: 15915380
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia.
    Roblot F; Imbert S; Godet C; Kauffmann C; Ragot S; Le Moal G; Roblot P; Rodier MH; Robert R; Becq-Giraudon B; Guilhot F
    Scand J Infect Dis; 2004; 36(11-12):848-54. PubMed ID: 15764172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a serum beta-glucan assay for diagnosis of HIV-related Pneumocystis jiroveci pneumonia in patients with negative microscopic examination results.
    Pisculli ML; Sax PE
    Clin Infect Dis; 2008 Jun; 46(12):1928-30. PubMed ID: 18540807
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemophagocytic syndrome associated with Hodgkin lymphoma and Pneumocystis jiroveci pneumonitis.
    Machaczka M; Vaktnas J
    Br J Haematol; 2007 Sep; 138(6):672. PubMed ID: 17655724
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive immunosuppressant reduction and long-term rejection risk in renal transplant recipients with Pneumocystis jiroveci pneumonia.
    Yang CY; Shih CJ; Yang WC; Lin CC
    Exp Clin Transplant; 2012 Aug; 10(4):344-9. PubMed ID: 22765304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual presentation of serum markers for suspected Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma.
    Uchiyama M; Ikeda T
    Int J Infect Dis; 2010 Mar; 14(3):e267-8. PubMed ID: 19665911
    [No Abstract]   [Full Text] [Related]  

  • 12. A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach.
    Zhang Y; Ai JW; Cui P; Zhang WH; Wu HL; Ye MZ
    J Infect; 2019 Feb; 78(2):158-169. PubMed ID: 30149030
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumocystis carinii pneumonia on F-18 FDG PET.
    Sojan SM; Chew G
    Clin Nucl Med; 2005 Nov; 30(11):763-4. PubMed ID: 16237310
    [No Abstract]   [Full Text] [Related]  

  • 14. [Induced sputum. Indication for examination in Pneumocystis carinii pneumonia?].
    von der Lippe E; Lier PA; Bruun JN; Boye NP
    Tidsskr Nor Laegeforen; 1995 Feb; 115(4):476-8. PubMed ID: 7871505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the cost-effectiveness of three staining methods for identification of Pneumocystis carinii in bronchoalveolar lavage fluid.
    Wiwanitkit V
    Trop Doct; 2005 Jan; 35(1):23-5. PubMed ID: 15712538
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of Toluidine Blue O staining for the diagnosis of Pneumocystis jiroveci in expectorated sputum sample and bronchoalveolar lavage from HIV-infected patients in a tertiary care referral center in Ethiopia.
    Aderaye G; Woldeamanuel Y; Asrat D; Lebbad M; Beser J; Worku A; Fernandez V; Lindquist L
    Infection; 2008 Jun; 36(3):237-43. PubMed ID: 18483698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative TaqMan PCR for detection of Pneumocystis jiroveci.
    Brancart F; Rodriguez-Villalobos H; Fonteyne PA; Peres-Bota D; Liesnard C
    J Microbiol Methods; 2005 Jun; 61(3):381-7. PubMed ID: 15767014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid Use and Pneumocystis Pneumonia Prophylaxis: A Teachable Moment.
    LoPiccolo J; Mehta SA; Lipson EJ
    JAMA Intern Med; 2018 Aug; 178(8):1106-1107. PubMed ID: 29913012
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor metabolic phenotypes on 18F FDG PET.
    Wong CY; Khong PL
    J Nucl Med; 2009 Jun; 50(6):1010-1; author reply 1011-12. PubMed ID: 19443584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pnemocystis jiroveci pneumonia: Comparison between conventional PCR and staining techniques].
    Kaouech E; Kallel K; Anane S; Belhadj S; Abdellatif S; Mnif K; Ben Othmane T; Ben Lakhal S; Kilani B; Ben Châabane T; Chaker E
    Pathol Biol (Paris); 2009 Jul; 57(5):373-7. PubMed ID: 19038508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.